EDGAR Filing Documents for 0000929638-24-002596

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0000929638-24-002596

Filing Date

2024-07-25

Accepted

2024-07-25 20:30:09

Documents

Period of Report

2024-07-22

Document Format Files

Seq	Description	Document	Type	Size
1		form3.html	3
1		form3.xml	3	2787
2	POWER OF ATTORNEY	exhibit24.htm	EX-24	4770
	Complete submission text file	0000929638-24-002596.txt		8967

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1

Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888

enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1

Business Address

Pruthi Raj Som (Reporting) CIK: 0002030291 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41854 | Film No.: 241143354